Dexcom (DXCM) Current Assets (2010 - 2026)

Dexcom (DXCM) has reported Current Assets for 17 consecutive years, with $4.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets fell 18.76% year-over-year to $4.1 billion in Q2 2026; TTM through Jun 2026 was $4.1 billion, a 18.76% decrease from a year earlier, with the FY2025 full-year figure at $4.0 billion, down 6.23% from the prior year.
• Current Assets was $4.1 billion for Q2 2026 at Dexcom, down from $4.3 billion in the prior quarter.
• Over five years, Current Assets peaked at $5.2 billion in Q3 2025 and troughed at $3.4 billion in Q3 2022.
• A 5-year average of $4.3 billion and a median of $4.3 billion in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 38.25% in 2023 and slipped 18.76% in 2026, its largest moves.
• Over 5 years, Current Assets stood at $3.7 billion in 2022, then rose by 20.64% to $4.4 billion in 2023, then retreated by 2.81% to $4.3 billion in 2024, then dropped by 6.23% to $4.0 billion in 2025, then grew by 1.32% to $4.1 billion in 2026.
• The last three Current Assets figures came in at $4.1 billion (Q2 2026), $4.3 billion (Q1 2026), and $4.0 billion (Q4 2025), per Business Quant data.